EPIGENE.COM
DEAD

Serial Number

85202806

Owner

Epigenesis Pharmaceuticals, LLC

Filing Date

Dec 21, 2010

Add to watchlist:

No watchlists yet
View on USPTO

EPIGENE.COM Trademark

Serial Number: 85202806

EPIGENE.COM is a trademark filed by Epigenesis Pharmaceuticals, LLC on December 21, 2010. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Epigenesis Pharmaceuticals, LLC (13 trademarks)

2009 Eastpark Boulevard
Cranbury, NJ 08512

Entity Type: 16

Trademark Details

Filing Date

December 21, 2010

Registration Date

Not Registered

Published for Opposition

May 17, 2011

Goods & Services

medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ards), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (svt), adenosine stress tests, infantile respiratory distress syndrome (infantile rds), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (copd), as well as cancers including leukemias, lymphomas, carcinomas, and the like, e.g., colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, e.g., cancers which metastasized to the lung(s), breast, liver and prostate

Filing History

UNDELIVERABLE MAIL - NO ACTION TAKEN
Mar 9, 2012 UNDN
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Feb 13, 2012 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 13, 2012 ABN6
UNDELIVERABLE MAIL - NO ACTION TAKEN
Jul 26, 2011 UNDN
UNDELIVERABLE MAIL - NO ACTION TAKEN
Jul 22, 2011 UNDN
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jul 12, 2011 NOAM
NOTICE OF PUBLICATION
May 18, 2011 NPUB
PUBLISHED FOR OPPOSITION
May 17, 2011 PUBO
WITHDRAWAL OF ATTORNEY GRANTED
May 5, 2011 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
May 5, 2011 WOAR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 9, 2011 PREV
ASSIGNED TO LIE
Apr 9, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 29, 2011 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 29, 2011 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 29, 2011 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 29, 2011 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 29, 2011 CNEA
ASSIGNED TO EXAMINER
Mar 21, 2011 DOCK
NOTICE OF PSEUDO MARK MAILED
Dec 31, 2010 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 30, 2010 NWOS
NEW APPLICATION ENTERED
Dec 24, 2010 NWAP